epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Rapiblyk

landiolol

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ

supraventricular tachycardia

[normal cardiac function]
Dose: 9-36 mcg/kg/min IV for up to 24h; Start: 9 mcg/kg/min IV, titrate by 9 mcg/kg/min IV q10min; Max: 36 mcg/kg/min; Info: taper dose gradually to D/C
[impaired cardiac function]
Dose: 1-36 mcg/kg/min IV for up to 24h; Start: 1 mcg/kg/min IV, titrate by 1 mcg/kg/min IV q15min; Max: 36 mcg/kg/min; Info: taper dose gradually to D/C

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A: consider decr. usual titration dose or frequency; Child-Pugh Class B or C: not defined

Peds Dosing .

Dosage forms:  INJ

supraventricular tachycardia

[normal cardiac function]
Dose: 9-36 mcg/kg/min IV for up to 24h; Start: 9 mcg/kg/min IV, titrate by 9 mcg/kg/min IV q10min; Max: 36 mcg/kg/min; Info: taper dose gradually to D/C

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A: consider decr. usual titration dose or frequency; Child-Pugh Class B or C: not defined

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@32948fe7
  • hypersensitivity to drug or ingredient
  • sinus bradycardia, severe
  • sick sinus syndrome
  • AV block, 2nd-3rd degree
  • heart failure, decompensated
  • cardiogenic shock
  • pulmonary HTN
  • abrupt withdrawal
  • caution: anaphylactic reaction history, severe
  • caution: renal impairment
  • caution: hepatic impairment
  • caution: AV block, 1st degree
  • caution: sinus node dysfunction
  • caution: cardiac conduction defect
  • caution: reactive airway disease
  • caution: CAD
  • caution: Prinzmetal angina
  • caution: pheochromocytoma
  • caution: hypotension
  • caution: hypovolemia
  • caution: Raynaud phenomenon
  • caution: PVD
  • caution: hyperthyroidism
  • caution: diabetes mellitus
  • caution: surgery, major
  • caution: fasting

Drug Interactions .

Overview

landiolol

beta blocker

Interaction Characteristics:
  • antihypertensive agent
  • bradycardia
  • delays atrioventricular conduction
  • hyperkalemia
  • hypotensive effects

Avoid/Use Alternative

  • acebutolol
  • Rapiblyk (landiolol)
    +
    acebutolol
    1 interaction

    Avoid/Use Alternative

    landiolol + acebutolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • adenosine
  • Rapiblyk (landiolol)
    +
    adenosine
    1 interaction

    Avoid/Use Alternative

    landiolol + adenosine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • albuterol
  • Rapiblyk (landiolol)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    landiolol + albuterol

    use alternative or monitor HR, BP, asthma sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • albuterol inhaled
  • Rapiblyk (landiolol)
    +
    albuterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + albuterol inhaled

    use alternative or monitor HR, BP, asthma sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • aldesleukin
  • Rapiblyk (landiolol)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    landiolol + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • alectinib
  • Rapiblyk (landiolol)
    +
    alectinib
    1 interaction

    Avoid/Use Alternative

    landiolol + alectinib

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • alfentanil
  • Rapiblyk (landiolol)
    +
    alfentanil
    1 interaction

    Avoid/Use Alternative

    landiolol + alfentanil

    avoid combo: combo may incr. risk of severe hypotension (including orthostasis, syncope), bradycardia (additive effects)

  • amiloride
  • Rapiblyk (landiolol)
    +
    amiloride
    1 interaction

    Avoid/Use Alternative

    landiolol + amiloride

    if hypokalemia use, monitor BP, potassium, especially if renal impairment; otherwise, avoid combo: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • amiodarone
  • Rapiblyk (landiolol)
    +
    amiodarone
    1 interaction

    Avoid/Use Alternative

    landiolol + amiodarone

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • amphetamine
  • Rapiblyk (landiolol)
    +
    amphetamine
    1 interaction

    Avoid/Use Alternative

    landiolol + amphetamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • angiotensin II
  • Rapiblyk (landiolol)
    +
    angiotensin II
    1 interaction

    Avoid/Use Alternative

    landiolol + angiotensin II

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • apraclonidine ophthalmic
  • Rapiblyk (landiolol)
    +
    apraclonidine ophthalmic
    1 interaction

    Avoid/Use Alternative

    landiolol + apraclonidine ophthalmic

    avoid combo if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, bradycardia (additive effects)

  • arformoterol inhaled
  • Rapiblyk (landiolol)
    +
    arformoterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + arformoterol inhaled

    use alternative or monitor HR, BP, COPD sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • armodafinil
  • Rapiblyk (landiolol)
    +
    armodafinil
    1 interaction

    Avoid/Use Alternative

    landiolol + armodafinil

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • arsenic trioxide
  • Rapiblyk (landiolol)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    landiolol + arsenic trioxide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • articaine
  • Rapiblyk (landiolol)
    +
    articaine
    1 interaction

    Avoid/Use Alternative

    landiolol + articaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • atazanavir
  • Rapiblyk (landiolol)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    landiolol + atazanavir

    use alternative or monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • atenolol
  • Rapiblyk (landiolol)
    +
    atenolol
    1 interaction

    Avoid/Use Alternative

    landiolol + atenolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • atomoxetine
  • Rapiblyk (landiolol)
    +
    atomoxetine
    1 interaction

    Avoid/Use Alternative

    landiolol + atomoxetine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • benzphetamine
  • Rapiblyk (landiolol)
    +
    benzphetamine
    1 interaction

    Avoid/Use Alternative

    landiolol + benzphetamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • betaxolol
  • Rapiblyk (landiolol)
    +
    betaxolol
    1 interaction

    Avoid/Use Alternative

    landiolol + betaxolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • betaxolol ophthalmic
  • Rapiblyk (landiolol)
    +
    betaxolol ophthalmic
    1 interaction

    Avoid/Use Alternative

    landiolol + betaxolol ophthalmic

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • bisoprolol
  • Rapiblyk (landiolol)
    +
    bisoprolol
    1 interaction

    Avoid/Use Alternative

    landiolol + bisoprolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • brigatinib
  • Rapiblyk (landiolol)
    +
    brigatinib
    1 interaction

    Avoid/Use Alternative

    landiolol + brigatinib

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • bupivacaine
  • Rapiblyk (landiolol)
    +
    bupivacaine
    1 interaction

    Avoid/Use Alternative

    landiolol + bupivacaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • bupivacaine liposomal
  • Rapiblyk (landiolol)
    +
    bupivacaine liposomal
    1 interaction

    Avoid/Use Alternative

    landiolol + bupivacaine liposomal

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • bupropion
  • Rapiblyk (landiolol)
    +
    bupropion
    1 interaction

    Avoid/Use Alternative

    landiolol + bupropion

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • carbamazepine
  • Rapiblyk (landiolol)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    landiolol + carbamazepine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • carteolol ophthalmic
  • Rapiblyk (landiolol)
    +
    carteolol ophthalmic
    1 interaction

    Avoid/Use Alternative

    landiolol + carteolol ophthalmic

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • carvedilol
  • Rapiblyk (landiolol)
    +
    carvedilol
    1 interaction

    Avoid/Use Alternative

    landiolol + carvedilol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • ceritinib
  • Rapiblyk (landiolol)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    landiolol + ceritinib

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • chloroprocaine
  • Rapiblyk (landiolol)
    +
    chloroprocaine
    1 interaction

    Avoid/Use Alternative

    landiolol + chloroprocaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • clonidine
  • Rapiblyk (landiolol)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    landiolol + clonidine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, including orthostasis (additive effects)

  • clozapine
  • Rapiblyk (landiolol)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    landiolol + clozapine

    avoid combo: combo may incr. risk of severe bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • cocaine
  • Rapiblyk (landiolol)
    +
    cocaine
    1 interaction

    Avoid/Use Alternative

    landiolol + cocaine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • crizotinib
  • Rapiblyk (landiolol)
    +
    crizotinib
    1 interaction

    Avoid/Use Alternative

    landiolol + crizotinib

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • desvenlafaxine
  • Rapiblyk (landiolol)
    +
    desvenlafaxine
    1 interaction

    Avoid/Use Alternative

    landiolol + desvenlafaxine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • dexmedetomidine
  • Rapiblyk (landiolol)
    +
    dexmedetomidine
    1 interaction

    Avoid/Use Alternative

    landiolol + dexmedetomidine

    avoid combo: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Rapiblyk (landiolol)
    +
    dexmedetomidine injection
    1 interaction

    Avoid/Use Alternative

    landiolol + dexmedetomidine injection

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, bradycardia (additive effects)

  • dexmethylphenidate
  • Rapiblyk (landiolol)
    +
    dexmethylphenidate
    1 interaction

    Avoid/Use Alternative

    landiolol + dexmethylphenidate

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • dextroamphetamine
  • Rapiblyk (landiolol)
    +
    dextroamphetamine
    1 interaction

    Avoid/Use Alternative

    landiolol + dextroamphetamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • diethylpropion
  • Rapiblyk (landiolol)
    +
    diethylpropion
    1 interaction

    Avoid/Use Alternative

    landiolol + diethylpropion

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • digoxin
  • Rapiblyk (landiolol)
    +
    digoxin
    1 interaction

    Avoid/Use Alternative

    landiolol + digoxin

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • dihydroergotamine
  • Rapiblyk (landiolol)
    +
    dihydroergotamine
    1 interaction

    Avoid/Use Alternative

    landiolol + dihydroergotamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • diltiazem
  • Rapiblyk (landiolol)
    +
    diltiazem
    1 interaction

    Avoid/Use Alternative

    landiolol + diltiazem

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension (additive effects)

  • disopyramide
  • Rapiblyk (landiolol)
    +
    disopyramide
    1 interaction

    Avoid/Use Alternative

    landiolol + disopyramide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • dobutamine
  • Rapiblyk (landiolol)
    +
    dobutamine
    1 interaction

    Avoid/Use Alternative

    landiolol + dobutamine

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • donepezil
  • Rapiblyk (landiolol)
    +
    donepezil
    1 interaction

    Avoid/Use Alternative

    landiolol + donepezil

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • dopamine
  • Rapiblyk (landiolol)
    +
    dopamine
    1 interaction

    Avoid/Use Alternative

    landiolol + dopamine

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • doxapram
  • Rapiblyk (landiolol)
    +
    doxapram
    1 interaction

    Avoid/Use Alternative

    landiolol + doxapram

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • dronedarone
  • Rapiblyk (landiolol)
    +
    dronedarone
    1 interaction

    Avoid/Use Alternative

    landiolol + dronedarone

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • droxidopa
  • Rapiblyk (landiolol)
    +
    droxidopa
    1 interaction

    Avoid/Use Alternative

    landiolol + droxidopa

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • dulaglutide
  • Rapiblyk (landiolol)
    +
    dulaglutide
    1 interaction

    Avoid/Use Alternative

    landiolol + dulaglutide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • eliglustat
  • Rapiblyk (landiolol)
    +
    eliglustat
    1 interaction

    Avoid/Use Alternative

    landiolol + eliglustat

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • ensartinib
  • Rapiblyk (landiolol)
    +
    ensartinib
    1 interaction

    Avoid/Use Alternative

    landiolol + ensartinib

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • ephedra
  • Rapiblyk (landiolol)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    landiolol + ephedra

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • ephedrine injection
  • Rapiblyk (landiolol)
    +
    ephedrine injection
    1 interaction

    Avoid/Use Alternative

    landiolol + ephedrine injection

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • ephedrine oral
  • Rapiblyk (landiolol)
    +
    ephedrine oral
    1 interaction

    Avoid/Use Alternative

    landiolol + ephedrine oral

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • epinephrine
  • Rapiblyk (landiolol)
    +
    epinephrine
    1 interaction

    Avoid/Use Alternative

    landiolol + epinephrine

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • epinephrine inhaled
  • Rapiblyk (landiolol)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + epinephrine inhaled

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • ergotamine
  • Rapiblyk (landiolol)
    +
    ergotamine
    1 interaction

    Avoid/Use Alternative

    landiolol + ergotamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • esketamine
  • Rapiblyk (landiolol)
    +
    esketamine
    1 interaction

    Avoid/Use Alternative

    landiolol + esketamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • esmolol
  • Rapiblyk (landiolol)
    +
    esmolol
    1 interaction

    Avoid/Use Alternative

    landiolol + esmolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • ethanol (alcoholic beverage)
  • Rapiblyk (landiolol)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    landiolol + ethanol (alcoholic beverage)

    use alternative or monitor HR, BP: combo may alter BP control, initially incr. risk of severe hypotension, followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • etrasimod
  • Rapiblyk (landiolol)
    +
    etrasimod
    1 interaction

    Avoid/Use Alternative

    landiolol + etrasimod

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • fenfluramine
  • Rapiblyk (landiolol)
    +
    fenfluramine
    1 interaction

    Avoid/Use Alternative

    landiolol + fenfluramine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • fentanyl
  • Rapiblyk (landiolol)
    +
    fentanyl
    1 interaction

    Avoid/Use Alternative

    landiolol + fentanyl

    avoid combo: combo may incr. risk of severe hypotension (including orthostasis, syncope), bradycardia (additive effects)

  • fexinidazole
  • Rapiblyk (landiolol)
    +
    fexinidazole
    1 interaction

    Avoid/Use Alternative

    landiolol + fexinidazole

    if possible, do not initiate fexinidazole until 5 half-lives after landiolol D/C; use alternative or monitor ECG during and x7 days after fexinidazole tx: combo may incr. risk of QT prolongation, cardiac arrhythmias (bradycardia may incr. risk of QT prolongation)

  • fingolimod
  • Rapiblyk (landiolol)
    +
    fingolimod
    1 interaction

    Avoid/Use Alternative

    landiolol + fingolimod

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • flecainide
  • Rapiblyk (landiolol)
    +
    flecainide
    1 interaction

    Avoid/Use Alternative

    landiolol + flecainide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • formoterol inhaled
  • Rapiblyk (landiolol)
    +
    formoterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + formoterol inhaled

    use alternative or monitor HR, BP, COPD sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • fosphenytoin
  • Rapiblyk (landiolol)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    landiolol + fosphenytoin

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • gadobenate dimeglumine
  • Rapiblyk (landiolol)
    +
    gadobenate dimeglumine
    1 interaction

    Avoid/Use Alternative

    landiolol + gadobenate dimeglumine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • galantamine
  • Rapiblyk (landiolol)
    +
    galantamine
    1 interaction

    Avoid/Use Alternative

    landiolol + galantamine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • guanfacine
  • Rapiblyk (landiolol)
    +
    guanfacine
    1 interaction

    Avoid/Use Alternative

    landiolol + guanfacine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, including orthostasis (additive effects)

  • hoodia
  • Rapiblyk (landiolol)
    +
    hoodia
    1 interaction

    Avoid/Use Alternative

    landiolol + hoodia

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • isocarboxazid
  • Rapiblyk (landiolol)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    landiolol + isocarboxazid

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • ivabradine
  • Rapiblyk (landiolol)
    +
    ivabradine
    1 interaction

    Avoid/Use Alternative

    landiolol + ivabradine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • ketamine
  • Rapiblyk (landiolol)
    +
    ketamine
    1 interaction

    Avoid/Use Alternative

    landiolol + ketamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • labetalol
  • Rapiblyk (landiolol)
    +
    labetalol
    1 interaction

    Avoid/Use Alternative

    landiolol + labetalol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • lacosamide
  • Rapiblyk (landiolol)
    +
    lacosamide
    1 interaction

    Avoid/Use Alternative

    landiolol + lacosamide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • lamotrigine
  • Rapiblyk (landiolol)
    +
    lamotrigine
    1 interaction

    Avoid/Use Alternative

    landiolol + lamotrigine

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • lanreotide
  • Rapiblyk (landiolol)
    +
    lanreotide
    1 interaction

    Avoid/Use Alternative

    landiolol + lanreotide

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • levalbuterol inhaled
  • Rapiblyk (landiolol)
    +
    levalbuterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + levalbuterol inhaled

    use alternative or monitor HR, BP, asthma sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • levobunolol ophthalmic
  • Rapiblyk (landiolol)
    +
    levobunolol ophthalmic
    1 interaction

    Avoid/Use Alternative

    landiolol + levobunolol ophthalmic

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • levomilnacipran
  • Rapiblyk (landiolol)
    +
    levomilnacipran
    1 interaction

    Avoid/Use Alternative

    landiolol + levomilnacipran

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • lidocaine
  • Rapiblyk (landiolol)
    +
    lidocaine
    1 interaction

    Avoid/Use Alternative

    landiolol + lidocaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • linezolid
  • Rapiblyk (landiolol)
    +
    linezolid
    1 interaction

    Avoid/Use Alternative

    landiolol + linezolid

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • lisdexamfetamine
  • Rapiblyk (landiolol)
    +
    lisdexamfetamine
    1 interaction

    Avoid/Use Alternative

    landiolol + lisdexamfetamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • lisinopril
  • Rapiblyk (landiolol)
    +
    lisinopril
    1 interaction

    Avoid/Use Alternative

    landiolol + lisinopril

    consider alternative or monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • lofexidine
  • Rapiblyk (landiolol)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    landiolol + lofexidine

    avoid combo: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • lopinavir/ritonavir
  • Rapiblyk (landiolol)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    landiolol + lopinavir/ ritonavir

    use alternative or monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • lorlatinib
  • Rapiblyk (landiolol)
    +
    lorlatinib
    1 interaction

    Avoid/Use Alternative

    landiolol + lorlatinib

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • mefloquine
  • Rapiblyk (landiolol)
    +
    mefloquine
    1 interaction

    Avoid/Use Alternative

    landiolol + mefloquine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • mepivacaine
  • Rapiblyk (landiolol)
    +
    mepivacaine
    1 interaction

    Avoid/Use Alternative

    landiolol + mepivacaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • methamphetamine
  • Rapiblyk (landiolol)
    +
    methamphetamine
    1 interaction

    Avoid/Use Alternative

    landiolol + methamphetamine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • methylergonovine
  • Rapiblyk (landiolol)
    +
    methylergonovine
    1 interaction

    Avoid/Use Alternative

    landiolol + methylergonovine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • methylphenidate
  • Rapiblyk (landiolol)
    +
    methylphenidate
    1 interaction

    Avoid/Use Alternative

    landiolol + methylphenidate

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • metoprolol
  • Rapiblyk (landiolol)
    +
    metoprolol
    1 interaction

    Avoid/Use Alternative

    landiolol + metoprolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • midodrine
  • Rapiblyk (landiolol)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    landiolol + midodrine

    avoid combo: combo may incr. risk of bradycardia; may decr. efficacy of both drugs (additive effects; antagonistic effects)

  • milnacipran
  • Rapiblyk (landiolol)
    +
    milnacipran
    1 interaction

    Avoid/Use Alternative

    landiolol + milnacipran

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • mirabegron
  • Rapiblyk (landiolol)
    +
    mirabegron
    1 interaction

    Avoid/Use Alternative

    landiolol + mirabegron

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • modafinil
  • Rapiblyk (landiolol)
    +
    modafinil
    1 interaction

    Avoid/Use Alternative

    landiolol + modafinil

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • nadolol
  • Rapiblyk (landiolol)
    +
    nadolol
    1 interaction

    Avoid/Use Alternative

    landiolol + nadolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • nebivolol
  • Rapiblyk (landiolol)
    +
    nebivolol
    1 interaction

    Avoid/Use Alternative

    landiolol + nebivolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • neostigmine
  • Rapiblyk (landiolol)
    +
    neostigmine
    1 interaction

    Avoid/Use Alternative

    landiolol + neostigmine

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • nicotine
  • Rapiblyk (landiolol)
    +
    nicotine
    1 interaction

    Avoid/Use Alternative

    landiolol + nicotine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • norepinephrine
  • Rapiblyk (landiolol)
    +
    norepinephrine
    1 interaction

    Avoid/Use Alternative

    landiolol + norepinephrine

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • octreotide
  • Rapiblyk (landiolol)
    +
    octreotide
    1 interaction

    Avoid/Use Alternative

    landiolol + octreotide

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • olmesartan medoxomil
  • Rapiblyk (landiolol)
    +
    olmesartan medoxomil
    1 interaction

    Avoid/Use Alternative

    landiolol + olmesartan medoxomil

    consider alternative or monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • olodaterol inhaled
  • Rapiblyk (landiolol)
    +
    olodaterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + olodaterol inhaled

    use alternative or monitor HR, BP, COPD sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • ozanimod
  • Rapiblyk (landiolol)
    +
    ozanimod
    1 interaction

    Avoid/Use Alternative

    landiolol + ozanimod

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • pasireotide
  • Rapiblyk (landiolol)
    +
    pasireotide
    1 interaction

    Avoid/Use Alternative

    landiolol + pasireotide

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • perindopril
  • Rapiblyk (landiolol)
    +
    perindopril
    1 interaction

    Avoid/Use Alternative

    landiolol + perindopril

    consider alternative or monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • phendimetrazine
  • Rapiblyk (landiolol)
    +
    phendimetrazine
    1 interaction

    Avoid/Use Alternative

    landiolol + phendimetrazine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • phenelzine
  • Rapiblyk (landiolol)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    landiolol + phenelzine

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • phentermine
  • Rapiblyk (landiolol)
    +
    phentermine
    1 interaction

    Avoid/Use Alternative

    landiolol + phentermine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • phenylephrine
  • Rapiblyk (landiolol)
    +
    phenylephrine
    1 interaction

    Avoid/Use Alternative

    landiolol + phenylephrine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • phenylephrine injection
  • Rapiblyk (landiolol)
    +
    phenylephrine injection
    1 interaction

    Avoid/Use Alternative

    landiolol + phenylephrine injection

    use alternative or monitor HR, BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • phenytoin
  • Rapiblyk (landiolol)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    landiolol + phenytoin

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • pindolol
  • Rapiblyk (landiolol)
    +
    pindolol
    1 interaction

    Avoid/Use Alternative

    landiolol + pindolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • ponesimod
  • Rapiblyk (landiolol)
    +
    ponesimod
    1 interaction

    Avoid/Use Alternative

    landiolol + ponesimod

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • potassium chloride
  • Rapiblyk (landiolol)
    +
    potassium chloride
    1 interaction

    Avoid/Use Alternative

    landiolol + potassium chloride

    IV potassium chloride: use alternative or monitor potassium, ECG, especially if renal impairment; ORAL potassium: monitor potassium, ECG, especially if renal impairment: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium phosphate
  • Rapiblyk (landiolol)
    +
    potassium phosphate
    1 interaction

    Avoid/Use Alternative

    landiolol + potassium phosphate

    use alternative or monitor potassium, ECG, especially if renal impairment: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • praziquantel
  • Rapiblyk (landiolol)
    +
    praziquantel
    1 interaction

    Avoid/Use Alternative

    landiolol + praziquantel

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • procainamide
  • Rapiblyk (landiolol)
    +
    procainamide
    1 interaction

    Avoid/Use Alternative

    landiolol + procainamide

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • procarbazine
  • Rapiblyk (landiolol)
    +
    procarbazine
    1 interaction

    Avoid/Use Alternative

    landiolol + procarbazine

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • propafenone
  • Rapiblyk (landiolol)
    +
    propafenone
    1 interaction

    Avoid/Use Alternative

    landiolol + propafenone

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension (additive effects)

  • propofol
  • Rapiblyk (landiolol)
    +
    propofol
    1 interaction

    Avoid/Use Alternative

    landiolol + propofol

    avoid combo: combo may incr. risk of severe hypotension, bradycardia (additive effects)

  • propranolol
  • Rapiblyk (landiolol)
    +
    propranolol
    1 interaction

    Avoid/Use Alternative

    landiolol + propranolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • pseudoephedrine
  • Rapiblyk (landiolol)
    +
    pseudoephedrine
    1 interaction

    Avoid/Use Alternative

    landiolol + pseudoephedrine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • pyridostigmine
  • Rapiblyk (landiolol)
    +
    pyridostigmine
    1 interaction

    Avoid/Use Alternative

    landiolol + pyridostigmine

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • quinidine (antiarrhythmic)
  • Rapiblyk (landiolol)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Avoid/Use Alternative

    landiolol + quinidine (antiarrhythmic)

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • quinine
  • Rapiblyk (landiolol)
    +
    quinine
    1 interaction

    Avoid/Use Alternative

    landiolol + quinine

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • rasagiline
  • Rapiblyk (landiolol)
    +
    rasagiline
    1 interaction

    Avoid/Use Alternative

    landiolol + rasagiline

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • regadenoson
  • Rapiblyk (landiolol)
    +
    regadenoson
    1 interaction

    Avoid/Use Alternative

    landiolol + regadenoson

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • remifentanil
  • Rapiblyk (landiolol)
    +
    remifentanil
    1 interaction

    Avoid/Use Alternative

    landiolol + remifentanil

    avoid combo: combo may incr. risk of severe hypotension (including orthostasis, syncope), bradycardia (additive effects)

  • remimazolam
  • Rapiblyk (landiolol)
    +
    remimazolam
    1 interaction

    Avoid/Use Alternative

    landiolol + remimazolam

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • ritonavir
  • Rapiblyk (landiolol)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    landiolol + ritonavir

    use alternative or monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • rivastigmine
  • Rapiblyk (landiolol)
    +
    rivastigmine
    1 interaction

    Avoid/Use Alternative

    landiolol + rivastigmine

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • ropinirole
  • Rapiblyk (landiolol)
    +
    ropinirole
    1 interaction

    Avoid/Use Alternative

    landiolol + ropinirole

    use alternative or monitor HR, BP: combo incr. risk of hypotension, including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • ropivacaine
  • Rapiblyk (landiolol)
    +
    ropivacaine
    1 interaction

    Avoid/Use Alternative

    landiolol + ropivacaine

    avoid combo: combo may incr. risk of hypotension, bradycardia (additive effects)

  • rotigotine transdermal
  • Rapiblyk (landiolol)
    +
    rotigotine transdermal
    1 interaction

    Avoid/Use Alternative

    landiolol + rotigotine transdermal

    use alternative or monitor HR, BP: combo incr. risk of severe hypotension, including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • safinamide
  • Rapiblyk (landiolol)
    +
    safinamide
    1 interaction

    Avoid/Use Alternative

    landiolol + safinamide

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • salmeterol inhaled
  • Rapiblyk (landiolol)
    +
    salmeterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + salmeterol inhaled

    use alternative or monitor HR, BP, asthma sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • selegiline
  • Rapiblyk (landiolol)
    +
    selegiline
    1 interaction

    Avoid/Use Alternative

    landiolol + selegiline

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • selegiline transdermal
  • Rapiblyk (landiolol)
    +
    selegiline transdermal
    1 interaction

    Avoid/Use Alternative

    landiolol + selegiline transdermal

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • siponimod
  • Rapiblyk (landiolol)
    +
    siponimod
    1 interaction

    Avoid/Use Alternative

    landiolol + siponimod

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • solriamfetol
  • Rapiblyk (landiolol)
    +
    solriamfetol
    1 interaction

    Avoid/Use Alternative

    landiolol + solriamfetol

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • sotalol
  • Rapiblyk (landiolol)
    +
    sotalol
    1 interaction

    Avoid/Use Alternative

    landiolol + sotalol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • succinylcholine
  • Rapiblyk (landiolol)
    +
    succinylcholine
    1 interaction

    Avoid/Use Alternative

    landiolol + succinylcholine

    avoid combo: combo may incr. risk of bradycardia, hyperkalemia (additive effects)

  • sufentanil
  • Rapiblyk (landiolol)
    +
    sufentanil
    1 interaction

    Avoid/Use Alternative

    landiolol + sufentanil

    avoid combo: combo may incr. risk of severe hypotension (including orthostasis, syncope), bradycardia (additive effects)

  • sugammadex
  • Rapiblyk (landiolol)
    +
    sugammadex
    1 interaction

    Avoid/Use Alternative

    landiolol + sugammadex

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • tacrolimus
  • Rapiblyk (landiolol)
    +
    tacrolimus
    1 interaction

    Avoid/Use Alternative

    landiolol + tacrolimus

    consider alternative or monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • terbutaline
  • Rapiblyk (landiolol)
    +
    terbutaline
    1 interaction

    Avoid/Use Alternative

    landiolol + terbutaline

    use alternative or monitor HR, BP, bronchospasm sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • thalidomide
  • Rapiblyk (landiolol)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    landiolol + thalidomide

    avoid combo: combo may incr. risk of bradycardia, hypotension, including orthostasis (additive effects)

  • ticagrelor
  • Rapiblyk (landiolol)
    +
    ticagrelor
    1 interaction

    Avoid/Use Alternative

    landiolol + ticagrelor

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • timolol
  • Rapiblyk (landiolol)
    +
    timolol
    1 interaction

    Avoid/Use Alternative

    landiolol + timolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • timolol ophthalmic
  • Rapiblyk (landiolol)
    +
    timolol ophthalmic
    1 interaction

    Avoid/Use Alternative

    landiolol + timolol ophthalmic

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • tranylcypromine
  • Rapiblyk (landiolol)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    landiolol + tranylcypromine

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

  • valsartan
  • Rapiblyk (landiolol)
    +
    valsartan
    1 interaction

    Avoid/Use Alternative

    landiolol + valsartan

    consider alternative or monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • vasopressin
  • Rapiblyk (landiolol)
    +
    vasopressin
    1 interaction

    Avoid/Use Alternative

    landiolol + vasopressin

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • venlafaxine
  • Rapiblyk (landiolol)
    +
    venlafaxine
    1 interaction

    Avoid/Use Alternative

    landiolol + venlafaxine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • verapamil
  • Rapiblyk (landiolol)
    +
    verapamil
    1 interaction

    Avoid/Use Alternative

    landiolol + verapamil

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension (additive effects)

  • vilanterol inhaled
  • Rapiblyk (landiolol)
    +
    vilanterol inhaled
    1 interaction

    Avoid/Use Alternative

    landiolol + vilanterol inhaled

    use alternative or monitor HR, BP, bronchospasm sx: combo may decr. efficacy of both drugs (antagonistic effects)

  • viloxazine
  • Rapiblyk (landiolol)
    +
    viloxazine
    1 interaction

    Avoid/Use Alternative

    landiolol + viloxazine

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • yohimbe
  • Rapiblyk (landiolol)
    +
    yohimbe
    1 interaction

    Avoid/Use Alternative

    landiolol + yohimbe

    use alternative or monitor HR, BP, especially w/ high yohimbe doses: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope; may decr. landiolol efficacy (additive effects; antagonistic effects)

Monitor/Modify Tx

  • alfuzosin
  • Rapiblyk (landiolol)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    landiolol + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Rapiblyk (landiolol)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    landiolol + aliskiren

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • alprostadil intracavernous
  • Rapiblyk (landiolol)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    landiolol + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Rapiblyk (landiolol)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    landiolol + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Rapiblyk (landiolol)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    landiolol + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amitriptyline
  • Rapiblyk (landiolol)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    landiolol + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Rapiblyk (landiolol)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    landiolol + amlodipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • amoxapine
  • Rapiblyk (landiolol)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    landiolol + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • apomorphine
  • Rapiblyk (landiolol)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    landiolol + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • aprocitentan
  • Rapiblyk (landiolol)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    landiolol + aprocitentan

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • aripiprazole bimonthly injection
  • Rapiblyk (landiolol)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    landiolol + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole lauroxil
  • Rapiblyk (landiolol)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    landiolol + aripiprazole lauroxil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole monthly injection
  • Rapiblyk (landiolol)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    landiolol + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Rapiblyk (landiolol)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    landiolol + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • asenapine
  • Rapiblyk (landiolol)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    landiolol + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • avanafil
  • Rapiblyk (landiolol)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    landiolol + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Rapiblyk (landiolol)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    landiolol + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • benazepril
  • Rapiblyk (landiolol)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    landiolol + benazepril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • berberine
  • Rapiblyk (landiolol)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    landiolol + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bethanechol
  • Rapiblyk (landiolol)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    landiolol + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bexagliflozin
  • Rapiblyk (landiolol)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + bexagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Rapiblyk (landiolol)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    landiolol + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brexpiprazole
  • Rapiblyk (landiolol)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    landiolol + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Rapiblyk (landiolol)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    landiolol + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Rapiblyk (landiolol)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    landiolol + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Rapiblyk (landiolol)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    landiolol + bromocriptine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bumetanide
  • Rapiblyk (landiolol)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    landiolol + bumetanide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • buprenorphine
  • Rapiblyk (landiolol)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    landiolol + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Rapiblyk (landiolol)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    landiolol + butorphanol

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • cabergoline
  • Rapiblyk (landiolol)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    landiolol + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Rapiblyk (landiolol)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + canagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • candesartan cilexetil
  • Rapiblyk (landiolol)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    landiolol + candesartan cilexetil

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • cannabis
  • Rapiblyk (landiolol)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    landiolol + cannabis

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • captopril
  • Rapiblyk (landiolol)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    landiolol + captopril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • cariprazine
  • Rapiblyk (landiolol)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    landiolol + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • celecoxib
  • Rapiblyk (landiolol)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    landiolol + celecoxib

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • chlorothiazide
  • Rapiblyk (landiolol)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    landiolol + chlorothiazide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • chlorpromazine
  • Rapiblyk (landiolol)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    landiolol + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Rapiblyk (landiolol)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    landiolol + chlorthalidone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cilostazol
  • Rapiblyk (landiolol)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    landiolol + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • clevidipine
  • Rapiblyk (landiolol)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    landiolol + clevidipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • clofarabine
  • Rapiblyk (landiolol)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    landiolol + clofarabine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • clomipramine
  • Rapiblyk (landiolol)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    landiolol + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • codeine
  • Rapiblyk (landiolol)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    landiolol + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Rapiblyk (landiolol)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    landiolol + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cyclosporine
  • Rapiblyk (landiolol)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    landiolol + cyclosporine

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • dapagliflozin
  • Rapiblyk (landiolol)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + dapagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • decitabine
  • Rapiblyk (landiolol)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    landiolol + decitabine

    monitor potassium w/ IV decitabine use, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • denileukin diftitox
  • Rapiblyk (landiolol)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    landiolol + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Rapiblyk (landiolol)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    landiolol + desflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • desipramine
  • Rapiblyk (landiolol)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    landiolol + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • deutetrabenazine
  • Rapiblyk (landiolol)
    +
    deutetrabenazine
    1 interaction

    Monitor/Modify Tx

    landiolol + deutetrabenazine

    monitor HR, BP: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • diclofenac
  • Rapiblyk (landiolol)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    landiolol + diclofenac

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • diclofenac topical
  • Rapiblyk (landiolol)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    landiolol + diclofenac topical

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • diflunisal
  • Rapiblyk (landiolol)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    landiolol + diflunisal

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • dihydrocodeine
  • Rapiblyk (landiolol)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    landiolol + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • dinutuximab
  • Rapiblyk (landiolol)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    landiolol + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • dipyridamole
  • Rapiblyk (landiolol)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    landiolol + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • doxazosin
  • Rapiblyk (landiolol)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    landiolol + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Rapiblyk (landiolol)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    landiolol + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Rapiblyk (landiolol)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    landiolol + dronabinol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • drospirenone (contraceptive)
  • Rapiblyk (landiolol)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    landiolol + drospirenone (contraceptive)

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • drospirenone (hormone replacement)
  • Rapiblyk (landiolol)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    landiolol + drospirenone (hormone replacement)

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • duloxetine
  • Rapiblyk (landiolol)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    landiolol + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • empagliflozin
  • Rapiblyk (landiolol)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + empagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalapril
  • Rapiblyk (landiolol)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    landiolol + enalapril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • enalaprilat
  • Rapiblyk (landiolol)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    landiolol + enalaprilat

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • entacapone
  • Rapiblyk (landiolol)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    landiolol + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Rapiblyk (landiolol)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    landiolol + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • eplerenone
  • Rapiblyk (landiolol)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    landiolol + eplerenone

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • epoprostenol
  • Rapiblyk (landiolol)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    landiolol + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ertugliflozin
  • Rapiblyk (landiolol)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + ertugliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ethacrynic acid
  • Rapiblyk (landiolol)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    landiolol + ethacrynic acid

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ethanol injection
  • Rapiblyk (landiolol)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    landiolol + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • etodolac
  • Rapiblyk (landiolol)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    landiolol + etodolac

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • felodipine
  • Rapiblyk (landiolol)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    landiolol + felodipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • fenoldopam
  • Rapiblyk (landiolol)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    landiolol + fenoldopam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • fenoprofen
  • Rapiblyk (landiolol)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    landiolol + fenoprofen

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • ferumoxytol
  • Rapiblyk (landiolol)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    landiolol + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • finerenone
  • Rapiblyk (landiolol)
    +
    finerenone
    1 interaction

    Monitor/Modify Tx

    landiolol + finerenone

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • flaxseed
  • Rapiblyk (landiolol)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    landiolol + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flibanserin
  • Rapiblyk (landiolol)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    landiolol + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • fluphenazine
  • Rapiblyk (landiolol)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    landiolol + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurbiprofen
  • Rapiblyk (landiolol)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    landiolol + flurbiprofen

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • fosinopril
  • Rapiblyk (landiolol)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    landiolol + fosinopril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • foslevodopa
  • Rapiblyk (landiolol)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    landiolol + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • furosemide
  • Rapiblyk (landiolol)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    landiolol + furosemide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • garlic
  • Rapiblyk (landiolol)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    landiolol + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gilteritinib
  • Rapiblyk (landiolol)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    landiolol + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • haloperidol
  • Rapiblyk (landiolol)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    landiolol + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • heparin
  • Rapiblyk (landiolol)
    +
    heparin
    1 interaction

    Monitor/Modify Tx

    landiolol + heparin

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • hydralazine
  • Rapiblyk (landiolol)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    landiolol + hydralazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • hydrochlorothiazide
  • Rapiblyk (landiolol)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    landiolol + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • hydrocodone
  • Rapiblyk (landiolol)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    landiolol + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydromorphone
  • Rapiblyk (landiolol)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    landiolol + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ibuprofen
  • Rapiblyk (landiolol)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    landiolol + ibuprofen

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • iloperidone
  • Rapiblyk (landiolol)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    landiolol + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Rapiblyk (landiolol)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    landiolol + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Rapiblyk (landiolol)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    landiolol + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • indapamide
  • Rapiblyk (landiolol)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    landiolol + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • indomethacin
  • Rapiblyk (landiolol)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    landiolol + indomethacin

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • irbesartan
  • Rapiblyk (landiolol)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    landiolol + irbesartan

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • iron sucrose
  • Rapiblyk (landiolol)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    landiolol + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Rapiblyk (landiolol)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    landiolol + isoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isosorbide dinitrate
  • Rapiblyk (landiolol)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    landiolol + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Rapiblyk (landiolol)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    landiolol + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isradipine
  • Rapiblyk (landiolol)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    landiolol + isradipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ketoprofen
  • Rapiblyk (landiolol)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    landiolol + ketoprofen

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • ketorolac
  • Rapiblyk (landiolol)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    landiolol + ketorolac

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • levodopa
  • Rapiblyk (landiolol)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    landiolol + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Rapiblyk (landiolol)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    landiolol + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • losartan
  • Rapiblyk (landiolol)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    landiolol + losartan

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • loxapine
  • Rapiblyk (landiolol)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    landiolol + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Rapiblyk (landiolol)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    landiolol + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumateperone
  • Rapiblyk (landiolol)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    landiolol + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Rapiblyk (landiolol)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    landiolol + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Rapiblyk (landiolol)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    landiolol + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Rapiblyk (landiolol)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    landiolol + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meclofenamate
  • Rapiblyk (landiolol)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    landiolol + meclofenamate

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • mefenamic acid
  • Rapiblyk (landiolol)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    landiolol + mefenamic acid

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • meloxicam
  • Rapiblyk (landiolol)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    landiolol + meloxicam

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • meperidine
  • Rapiblyk (landiolol)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    landiolol + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methadone
  • Rapiblyk (landiolol)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    landiolol + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Rapiblyk (landiolol)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    landiolol + methohexital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • methyldopa
  • Rapiblyk (landiolol)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    landiolol + methyldopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Rapiblyk (landiolol)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    landiolol + methylene blue injection

    monitor HR, BP: combo may incr. risk of bradycardia, hypotension including orthostasis, syncope (additive effects)

  • metolazone
  • Rapiblyk (landiolol)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    landiolol + metolazone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • midazolam
  • Rapiblyk (landiolol)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    landiolol + midazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milrinone
  • Rapiblyk (landiolol)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    landiolol + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Rapiblyk (landiolol)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    landiolol + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Rapiblyk (landiolol)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    landiolol + minoxidil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • mirtazapine
  • Rapiblyk (landiolol)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    landiolol + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • moexipril
  • Rapiblyk (landiolol)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    landiolol + moexipril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • molindone
  • Rapiblyk (landiolol)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    landiolol + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • morphine
  • Rapiblyk (landiolol)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    landiolol + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nabumetone
  • Rapiblyk (landiolol)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    landiolol + nabumetone

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • nalbuphine
  • Rapiblyk (landiolol)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    landiolol + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • naphazoline ophthalmic
  • Rapiblyk (landiolol)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    landiolol + naphazoline ophthalmic

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • naproxen
  • Rapiblyk (landiolol)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    landiolol + naproxen

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • nattokinase
  • Rapiblyk (landiolol)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    landiolol + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • naxitamab
  • Rapiblyk (landiolol)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    landiolol + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • niacin (vitamin B3)
  • Rapiblyk (landiolol)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    landiolol + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicardipine
  • Rapiblyk (landiolol)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    landiolol + nicardipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nifedipine
  • Rapiblyk (landiolol)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    landiolol + nifedipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nilotinib
  • Rapiblyk (landiolol)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    landiolol + nilotinib

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • nimodipine
  • Rapiblyk (landiolol)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    landiolol + nimodipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nisoldipine
  • Rapiblyk (landiolol)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    landiolol + nisoldipine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitric oxide
  • Rapiblyk (landiolol)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    landiolol + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Rapiblyk (landiolol)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    landiolol + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Rapiblyk (landiolol)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    landiolol + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Rapiblyk (landiolol)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    landiolol + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Rapiblyk (landiolol)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    landiolol + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Rapiblyk (landiolol)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    landiolol + obinutuzumab

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • olanzapine
  • Rapiblyk (landiolol)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    landiolol + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Rapiblyk (landiolol)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    landiolol + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • opicapone
  • Rapiblyk (landiolol)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    landiolol + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Rapiblyk (landiolol)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    landiolol + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxaprozin
  • Rapiblyk (landiolol)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    landiolol + oxaprozin

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • oxazepam
  • Rapiblyk (landiolol)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    landiolol + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxycodone
  • Rapiblyk (landiolol)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    landiolol + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymetazoline nasal
  • Rapiblyk (landiolol)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    landiolol + oxymetazoline nasal

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Rapiblyk (landiolol)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    landiolol + oxymetazoline ophthalmic

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • oxymetazoline topical
  • Rapiblyk (landiolol)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    landiolol + oxymetazoline topical

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • oxymorphone
  • Rapiblyk (landiolol)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    landiolol + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • paliperidone
  • Rapiblyk (landiolol)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    landiolol + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Rapiblyk (landiolol)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    landiolol + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • paltusotine
  • Rapiblyk (landiolol)
    +
    paltusotine
    1 interaction

    Monitor/Modify Tx

    landiolol + paltusotine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • pentamidine
  • Rapiblyk (landiolol)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    landiolol + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Rapiblyk (landiolol)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    landiolol + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Rapiblyk (landiolol)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    landiolol + pentobarbital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perphenazine
  • Rapiblyk (landiolol)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    landiolol + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • phenobarbital
  • Rapiblyk (landiolol)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    landiolol + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Rapiblyk (landiolol)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    landiolol + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • phentolamine
  • Rapiblyk (landiolol)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    landiolol + phentolamine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • phenylephrine nasal
  • Rapiblyk (landiolol)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    landiolol + phenylephrine nasal

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Rapiblyk (landiolol)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    landiolol + phenylephrine ophthalmic

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • phenylephrine rectal
  • Rapiblyk (landiolol)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    landiolol + phenylephrine rectal

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • piroxicam
  • Rapiblyk (landiolol)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    landiolol + piroxicam

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • potassium acid phosphate
  • Rapiblyk (landiolol)
    +
    potassium acid phosphate
    1 interaction

    Monitor/Modify Tx

    landiolol + potassium acid phosphate

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • potassium bicarbonate
  • Rapiblyk (landiolol)
    +
    potassium bicarbonate
    1 interaction

    Monitor/Modify Tx

    landiolol + potassium bicarbonate

    monitor potassium, ECG, especially if renal impairment: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium citrate
  • Rapiblyk (landiolol)
    +
    potassium citrate
    1 interaction

    Monitor/Modify Tx

    landiolol + potassium citrate

    monitor potassium, ECG, especially if renal impairment: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium iodide
  • Rapiblyk (landiolol)
    +
    potassium iodide
    1 interaction

    Monitor/Modify Tx

    landiolol + potassium iodide

    monitor potassium, ECG, especially if renal impairment: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • pramipexole
  • Rapiblyk (landiolol)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    landiolol + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prazosin
  • Rapiblyk (landiolol)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    landiolol + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prochlorperazine
  • Rapiblyk (landiolol)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    landiolol + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Rapiblyk (landiolol)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    landiolol + promethazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • protriptyline
  • Rapiblyk (landiolol)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    landiolol + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quetiapine
  • Rapiblyk (landiolol)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    landiolol + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • quinapril
  • Rapiblyk (landiolol)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    landiolol + quinapril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • ramipril
  • Rapiblyk (landiolol)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    landiolol + ramipril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • riociguat
  • Rapiblyk (landiolol)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    landiolol + riociguat

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • risperidone
  • Rapiblyk (landiolol)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    landiolol + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Rapiblyk (landiolol)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    landiolol + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sevoflurane
  • Rapiblyk (landiolol)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    landiolol + sevoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sildenafil
  • Rapiblyk (landiolol)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    landiolol + sildenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • silodosin
  • Rapiblyk (landiolol)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    landiolol + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sodium ferric gluconate complex
  • Rapiblyk (landiolol)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    landiolol + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sotagliflozin
  • Rapiblyk (landiolol)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    landiolol + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sparsentan
  • Rapiblyk (landiolol)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    landiolol + sparsentan

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension (including orthostasis, syncope), hyperkalemia (additive effects)

  • spironolactone
  • Rapiblyk (landiolol)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    landiolol + spironolactone

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, severe hyperkalemia (additive effects)

  • sulindac
  • Rapiblyk (landiolol)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    landiolol + sulindac

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • tadalafil
  • Rapiblyk (landiolol)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    landiolol + tadalafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tagraxofusp
  • Rapiblyk (landiolol)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    landiolol + tagraxofusp

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tamsulosin
  • Rapiblyk (landiolol)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    landiolol + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Rapiblyk (landiolol)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    landiolol + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Rapiblyk (landiolol)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    landiolol + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • telmisartan
  • Rapiblyk (landiolol)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    landiolol + telmisartan

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • terazosin
  • Rapiblyk (landiolol)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    landiolol + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tetrabenazine
  • Rapiblyk (landiolol)
    +
    tetrabenazine
    1 interaction

    Monitor/Modify Tx

    landiolol + tetrabenazine

    monitor HR, BP: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • tetrahydrozoline ophthalmic
  • Rapiblyk (landiolol)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    landiolol + tetrahydrozoline ophthalmic

    monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • thioridazine
  • Rapiblyk (landiolol)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    landiolol + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Rapiblyk (landiolol)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    landiolol + thiothixene

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • tizanidine
  • Rapiblyk (landiolol)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    landiolol + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Rapiblyk (landiolol)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    landiolol + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolmetin
  • Rapiblyk (landiolol)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    landiolol + tolmetin

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • tolvaptan
  • Rapiblyk (landiolol)
    +
    tolvaptan
    1 interaction

    Monitor/Modify Tx

    landiolol + tolvaptan

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • torsemide
  • Rapiblyk (landiolol)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    landiolol + torsemide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tramadol
  • Rapiblyk (landiolol)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    landiolol + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Rapiblyk (landiolol)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    landiolol + trandolapril

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

  • trazodone
  • Rapiblyk (landiolol)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    landiolol + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Rapiblyk (landiolol)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    landiolol + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamterene
  • Rapiblyk (landiolol)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    landiolol + triamterene

    monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, severe hyperkalemia (additive effects)

  • trifluoperazine
  • Rapiblyk (landiolol)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    landiolol + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimethoprim
  • Rapiblyk (landiolol)
    +
    trimethoprim
    1 interaction

    Monitor/Modify Tx

    landiolol + trimethoprim

    monitor potassium, especially if renal impairment: combo may incr. risk of hyperkalemia (additive effects)

  • trimipramine
  • Rapiblyk (landiolol)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    landiolol + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • valbenazine
  • Rapiblyk (landiolol)
    +
    valbenazine
    1 interaction

    Monitor/Modify Tx

    landiolol + valbenazine

    monitor HR, BP: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • vardenafil
  • Rapiblyk (landiolol)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    landiolol + vardenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • vinpocetine
  • Rapiblyk (landiolol)
    +
    vinpocetine
    1 interaction

    Monitor/Modify Tx

    landiolol + vinpocetine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • voclosporin
  • Rapiblyk (landiolol)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    landiolol + voclosporin

    monitor potassium, especially if renal impairment: combo may incr. risk of severe hyperkalemia (additive effects)

  • vosoritide
  • Rapiblyk (landiolol)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    landiolol + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ziprasidone
  • Rapiblyk (landiolol)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    landiolol + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@5fc1818a
  • CHF
  • hypotension, severe
  • bradycardia, severe
  • heart block
  • angina exacerbation if abrupt D/C
  • MI if abrupt D/C
  • ventricular arrhythmia if abrupt D/C
  • hyperkalemia
  • bronchospasm

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@6550da31
  • hypotension

Safety/Monitoring .

Monitoring Parameters
electrolytes; BP; HR; ECG

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 2nd and 3rd trimesters; inadequate human data available, though possible risk of intrauterine growth restriction and neonatal adverse effects, including bradycardia, hypoglycemia and respiratory depression based on limited human data with other beta blockers; no known risk of embryo-fetal toxicity based on animal data at 2.7x MRHD

Lactation

Clinical Summary

monitor infant closely while breastfeeding; no human data available, though possible risk of infant bradycardia and hypoglycemia based on limited human data with other beta blockers and drug's mechanism of action; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@6066c858

Metabolism: for landiolol: plasma; CYP450: unknown; Info: active metabolite

Excretion: for landiolol: urine 89-99%; Half-life: 4-5min

Subclass: Antiarrhythmics, Parenteral ; Beta Blockers

Mechanism of Action
for landiolol: selectively antagonizes beta-1 adrenergic receptors (class II antiarrhythmic)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: AOP Orphan Pharmaceuticals

com.epocrates.rxweb.beans.DrugOtherInfoBean@761b8804

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information